STUDY ON RELATIVE GENE EXPRESSION LEVELS IN TUMOR TISSUE AND IN BLOOD SERUM OF CANCER PATIENTS

Authors

  • L.M. Kovalevska R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • T.V. Zadvornyi R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • T.A. Malysheva The State Institution Romodanov Neurosurgery Institute of NAMSU, Kyiv, Ukraine
  • S.S. Kalman R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • N.Yu. Lukianova R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • E.V. Kashuba R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine

DOI:

https://doi.org/10.32471/oncology.2663-7928.t-23-3-2021-g.9761

Keywords:

blood serum, extracellular RNA, gene expression, malignant neoplasms, quantitative PCR, tumor tissue

Abstract

Aim: to develop a method to assess relative gene expression at a level of extracellular RNA (exRNA) isolated from blood serum and total RNA obtained from tumor tissue samples, as well as at the protein level in malignant neoplasms. Object and methods: samples of blood serum and surgical material of 5 patients with brain glioblastomas and blood sera of 4 healthy donors. MRPS18-1 and MRPS18-2 proteins were determined by immunohistochemistry. Statistical analysis was performed, using GraphPadPrism9. Results: the MRPS18-2 gene shows a significant difference in extracellular mRNA levels in patients with brain gliomas and healthy donors. The expression of the MRPS18-2 gene at the mRNA level is not much different in blood serum and tumor tissue, that makes the MRPS18-2 gene a putative tumor marker. Conclusions: our data show the possibility of isolating a sufficient amount of extracellular mRNA from the blood serum of cancer patients for detection by qPCR. In addition to this pilot study, more patients, as well as samples from patients with various nosological forms, such as prostate and breast cancer, should be studied, to deve­lop a panel of non-invasive molecular markers for cancer diagnosis and/or prognosis.

 

References

Fedorenko Z, Michailovich Yu., Goulak L., et al. CANCER IN UKRAINE 2019-2020: Incidence, mortality, prevalence and other relevant statistics. Kyiv: National Cancer Registry of Ukraine (NCRU). 2021. http://www.ncru.inf.ua/publications/BULL_22/index_e.htm

Mishra S, Sharma S, Javed MN, et al. Bioinspired nanocomposites: applications in disease diagnosis and treatment. Pharm Nanotechnol 2019; 7 (3): 206–19.

Gubsky YI. Biological chemistry. Kyiv-Ternopil: Ukrmedknyha 2000. 508 p. (in Ukrainian)

Di Vizio D, Morello M, Dudley AC, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 2012; 181 (5): 1573–84.

Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol 2015; 40: 41–51.

Sadik N, Cruz L, Gurtner A, et al. Extracellular RNAs: a new awareness of old perspectives. Methods Mol Biol 2018; 1740: 1–15.

Yuan T, Huang X, Woodcock M, et al. Plasma extracellular RNA profiles in healthy and cancer patients. Sci Rep 2016; 6: 19413.

Savelyeva AV, Kuligina EV, Bariakin DN, et al. Variety of RNAs in peripheral blood cells, plasma, and plasma fractions. Biomed Res Int 2017; 2017: 7404912.

Jung YW, Shim JI, Shim SH, et al. Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia. Medicine (Baltimore) 2019; 98 (3): e13971.

Mushtaq M, Ali RH, Kashuba V, et al. S18 family of mitochondrial ribosomal proteins: evolutionary history and Gly132 polymorphism in colon carcinoma. Oncotarget 2016; 7 (34): 55649–62.

Kovalevska LM, Malysheva TA, Kalman SS, et al. Expression pattern of MRPS18 family genes in gliomas. Exp Oncol 2021; 43 (3): 204–8.

Larson MH, Pan W, Kim HJ, et al. A comprehensive characterization of the cell-free transcriptome reveals tissue-and subtype-specific biomarkers for cancer detection. Nat Commun 2021; 12 (1): 2357.

Moufarrej MN, Wong RJ, Shaw GM, et al. Investigating pregnancy and its complications using circulating cell-free RNA in women’s blood during gestation. Front Pediatr 2020; 8: 605219.

de Candia P, De Rosa V, Casiraghi M, Matarese G. Extracellular RNAs: a secret arm of immune system regulation. J Biol Chem 2016; 291 (14): 7221–8.

O’Brien K, Breyne K, Ughetto S, et al. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol 2020; 21 (10): 585–606.

Tomita T, Kato M, Mishima T, et al. Extracellular mRNA transported to the nucleus exerts translation-independent function. Nat Commun 2021; 12 (1): 3655.

Published

2021-07-27

How to Cite

Kovalevska , L., Zadvornyi , T., Malysheva , T., Kalman , S., Lukianova , N., & Kashuba , E. (2021). STUDY ON RELATIVE GENE EXPRESSION LEVELS IN TUMOR TISSUE AND IN BLOOD SERUM OF CANCER PATIENTS. Oncology, 23(3), 149–153. https://doi.org/10.32471/oncology.2663-7928.t-23-3-2021-g.9761

Issue

Section

Original investigations